289 results on '"Tendulkar, R.D."'
Search Results
2. Outcomes with Five Fraction Image-Guided Partial Breast Irradiation to Reduced Target Volumes
3. Five Fraction Accelerated Partial Breast Irradiation vs. Intraoperative Radiation Therapy for Early-Stage Breast Cancer
4. Patterns of Recurrence Following Radiation and ADT for Pathologic Lymph Node Positive Prostate Cancer: A Multi-Institutional Study
5. Recursive Partitioning Analysis to Define Prognostic Groups Using a Large Single Institution Experience of Multimodality Radiation Therapy for Bladder Cancer
6. Accelerated Partial Breast Irradiation vs. Intraoperative Radiation Therapy for Early-Stage Breast Cancer and Ductal Carcinoma In Situ
7. Trends in the Delivery of Accelerated Partial Breast Irradiation Therapy
8. Rates and Predictors of Acute Toxicity after Accelerated Partial Breast Irradiation
9. Comparison of Acute and Chronic Toxicities with Daily vs. QOD Partial Breast Radiation Therapy
10. Transcriptomic Features of Cribriform and Intraductal Carcinoma of the Prostate
11. Prostate Cancer Screening Disparities in Persons Experiencing Homelessness
12. Effects of the Virtual Match Process on Radiation Oncology Applicants' Interview Experience and their Approach to the Match
13. Prognostic Significance of the Risk of Non-localized Disease on PSMA/PET: Comparative Performance of a Novel, PSMA/PET-Derived Risk Stratification Tool for High-Risk Prostate Cancer in a Large, Multi-Institutional Cohort
14. Impact of Post-Mastectomy Radiation Therapy in Women With T1-2N1M0 Breast Cancer With Sentinel Lymph Node Biopsy Alone
15. Preliminary Report Assessing Resident and Faculty Evaluations Across Radiation Oncology Programs
16. The Relationship Between Androgen Deprivation Therapy Duration and External Beam Radiotherapy With or Without a Brachytherapy Boost in High-Risk Prostate Cancer
17. Identification of Putative Gene-Target Modulators of Radiosensitivity in Bladder Cancer Cell Lines (BlaCCL)
18. Cost-Effectiveness of Treatment Strategies for High-Risk Prostate Cancer
19. Impact of Evolving Margin Definitions Following Breast Conserving Surgery on Boost Utilization
20. Feasibility of Ultrasound-Based Intra-Fraction Motion Monitoring for Prostate Stereotactic Body Radiation Therapy
21. 125I Interstitial Brachytherapy with or without Androgen Deprivation Therapy among Unfavorable Risk Prostate Cancer
22. Impact of Post-Mastectomy Radiation Therapy (PMRT) in Women with T1-2N1M0 Breast Cancer: A Multi-Institutional Analysis
23. Transcriptomic and Mutational Analyses Identify Biological Processes Correlated with Bladder Cancer Cell Line (BlaCCL) Radiation Response
24. A Multi-institutional, Propensity Score-Weighted Comparison of Moderately Hypofractionated Photon and Proton Therapy for 1850 Patients with Low or Intermediate Risk Prostate Cancer
25. A Common Polymorphism in 3β-hydroxysteroid Dehydrogenase Promotes Resistance to Radiotherapy
26. Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost: Comparison of outcomes in a multi-institutional analysis of patients with high-risk prostate cancer
27. Evaluating the 2018 NCCN Classification System for Intermediate-risk Prostate Cancer Patients Undergoing External-beam Radiation Therapy
28. Initial Outcomes with an Image-Guided Five Fraction Accelerated Partial-Breast Irradiation Regimen Delivered with IMRT
29. Improvement in Cardiac Dosimetry by Optimizing Heart-Sparing Breast Radiotherapy
30. Monitoring Intra-Fraction Prostate Motion Using Kv Triggered Imaging during SBRT
31. A Comparison between External Beam Radiotherapy and Low Dose-Rate Brachytherapy for Definitive Treatment of Gleason 9&10 (ISUP 5) Prostate Cancer
32. Validation of the 2018 NCCN Prostate Cancer Risk Classification among 2,715 Patients Treated with Low Dose Rate I-125 Brachytherapy
33. Impact of Post-Prostatectomy Prostate Specific Antigen (PSA) Kinetics on Outcomes of Salvage Radiotherapy
34. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy with Brachytherapy Boost: Comparison of Outcomes in A Multi-Institutional Analysis of 4,086 Patients with High-Risk Prostate Cancer
35. Impact of Cribriform Pattern 4 and Intraductal Carcinoma on Gleason 7 Prostate Cancer Treated with External Beam Radiotherapy
36. Ten Year Outcomes of Locoregional and Distant Recurrence for T1-2N1 Breast Cancer with or Without Post-Mastectomy Radiotherapy
37. The Effect of the Timing of Biochemical Failure after External Beam Radiation Therapy or Low Dose-rate Brachytherapy for Definitive Prostate Cancer Treatment
38. Ten-Year Outcomes and Toxicity with Moderately Hypofractionated (70 Gy in 28 fractions) Intensity-Modulated Radiation Therapy for Localized Prostate Cancer.
39. Assessing Quality of Heart Contouring and Dosimetry in Treatment of Left Sided Breast Cancer Across Cancer Centers within an Integrated Health System
40. Leadership Training for U.S. Radiation Oncology Residents: Results of a Pilot Program
41. Tumor Gene Expression Profiling in Prostate Cancer (PCa) Identifies Molecular Taxonomies Associated with Node Positivity and Quantitative Imaging Features on Multiparametric MRI (mpMRI)
42. Comparing 10-Year Outcomes in Radiated Patients with Breast Autologous Reconstruction (AR) or Tissue Expander/Implant Based Reconstruction (TE/I)
43. Assessment of Cardiac Dosimetry and Additional Cardiac Risk Factors in Patients Undergoing Modern Breast Cancer Radiation Therapy
44. Effect of Margin Size and Image Guidance Method on Biochemical Failure and Toxicity in Prostate Cancer Treated with IMRT
45. Achieving “Zero PSA” Following Post-Prostatectomy Radiation Therapy for Lymph Node Positive Prostate Cancer in the Ultrasensitive PSA Era
46. Heterogeneous Dose-Escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer: Quality of Life and Clinical Outcomes of an Institutional Phase 2 Study
47. Comparing 10-Year Outcomes with Salvage Mastectomy Followed By Immediate Autologous Reconstruction or Tissue Expander/Implant Based Reconstruction in Patients with Locally Recurrent Breast Cancer after Breast Conservation Therapy
48. Surface Guided Radiation Therapy (SGRT): The Sensitivity of the Region of Interest (ROI) Selection on the Translational and Rotational Accuracy for Whole Breast Irradiation
49. The Importance of Treatment and Timing in Metaplastic Breast Cancer
50. The Effect of Androgen Deprivation Therapy on Prostate Cancer-Specific Mortality in Patients With High-Risk Prostate Cancer Treated with I-125 Brachytherapy as the Sole Radiation Therapeutic Modality
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.